Insider plans sale of 10,411 ordinary shares

A shareholder has filed a Rule 144 notice to sell 10,411 ordinary shares.

Rhea-AI Filing Summary

A shareholder has filed a Rule 144 notice to sell 10,411 ordinary shares. The shares are planned to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC at an aggregate market value of $140,027.95, with 187,693,059 shares outstanding.

The securities to be sold were acquired on 02/08/2026 through the vesting of restricted stock units as equity compensation from the issuer, with payment also dated 02/08/2026. The notice includes a representation that the seller is not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Rule 144 filing for WVE disclose about planned share sales?

The Rule 144 filing discloses a planned sale of 10,411 ordinary shares on NASDAQ. The shares are associated with issuer WVE and will be sold through Morgan Stanley Smith Barney LLC, reflecting a routine resale of previously acquired equity compensation.

How many WVE ordinary shares are planned to be sold and at what market value?

The notice covers 10,411 ordinary shares with an aggregate market value of $140,027.95. This value is based on market pricing at the time of the filing and indicates the approximate dollar size of the planned transaction for the selling holder.

How were the WVE shares in this Rule 144 notice acquired by the seller?

The 10,411 ordinary shares were acquired through restricted stock unit vesting on 02/08/2026. The acquisition is classified as equity compensation from the issuer, with the same date recorded for both the vesting event and the related equity payment.

On which exchange will the WVE shares in this Rule 144 filing be sold?

The ordinary shares referenced in the Rule 144 filing are planned to be sold on the NASDAQ exchange. The broker handling the transaction is Morgan Stanley Smith Barney LLC, operating from its Executive Financial Services office in New York.

What does the filer represent about undisclosed information in the WVE Rule 144 notice?

The filer represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is part of the signature section and aligns with Rule 144 and related securities law requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 09:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001657710
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Wave Life Sciences Ltd.
SEC File Number	001-37627
Address of Issuer	7 Straits View #12-00 Marina One East Tower Singapore SINGAPORE 18936
Phone	65-6236 3388
Name of Person for Whose Account the Securities are To Be Sold	PAUL BOLNO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ordinary shares	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10411	140027.95	187693059	02/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ordinary shares	02/08/2026	Restricted Stock Unit Vesting	ISSUER			10411	02/08/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
Date of Notice	02/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Paul Bolno
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)